Emergent Biosolutions Announces Preliminary 2015 Financial Results, Provides 2016 Financial Outlook, and Outlines New Five-Year Strategic Growth Plan Six products in clinical or advanced development, with at least three being dual use, prioritizing those with third party funding GAITHERSBURG, Md., Jan. 11, 2016 -- Emergent BioSolutions Inc. today announced preliminary unaudited 2015 financial results and provided guidance for 2016. The company also provided an overview of the key financial and operational goals to be achieved by year end 2020 through its next five-year strategic growth plan.